NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)

NeuroPace's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $54.0 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 18.53% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $54.0 million (down 18.53% YoY), while the FY2025 annual figure was $61.1 million, up 15.74% from the prior year.
• Cash & Current Investments was $54.0 million for Q1 2026 at NeuroPace, down from $61.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $103.2 million in Q1 2022 to a low of $52.8 million in Q4 2024.
• Historically, Cash & Current Investments has averaged $67.3 million across 5 years, with a median of $62.1 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments surged 237.95% in 2022, then sank 34.47% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $77.4 million in 2022, then decreased by 14.15% to $66.5 million in 2023, then declined by 20.61% to $52.8 million in 2024, then increased by 15.74% to $61.1 million in 2025, then dropped by 11.59% to $54.0 million in 2026.
• The last three Cash & Current Investments figures came in at $54.0 million (Q1 2026), $61.1 million (Q4 2025), and $60.0 million (Q3 2025), per Business Quant data.